Ono to Expand Cancer Portfolio with $2.4B Deciphera Acquisition
Ono Pharmaceutical has agreed to acquire Deciphera Pharmaceuticals for $2.4 billion, the companies said today, in a deal designed to grow the buyer’s oncology portfolio with an approved therapy, a second cancer treatment expected to begin regulatory review …